[Treatment of adult T-cell leukemia-lymphoma]

Rinsho Ketsueki. 2014 Oct;55(10):1952-61.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Allografts
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Carboplatin / administration & dosage
  • Clinical Trials as Topic
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Doxorubicin / analogs & derivatives
  • Epirubicin / administration & dosage
  • Etoposide / administration & dosage
  • Hematopoietic Stem Cell Transplantation*
  • Human T-lymphotropic virus 1
  • Humans
  • Interferon-alpha / administration & dosage
  • Leukemia-Lymphoma, Adult T-Cell / epidemiology
  • Leukemia-Lymphoma, Adult T-Cell / therapy*
  • Leukemia-Lymphoma, Adult T-Cell / virology
  • Methotrexate / administration & dosage
  • Nitrosourea Compounds / administration & dosage
  • Prednisolone / administration & dosage
  • Prednisone / administration & dosage
  • Prognosis
  • Salvage Therapy
  • Vincristine / administration & dosage
  • Vindesine / administration & dosage
  • Zidovudine / administration & dosage

Substances

  • Antibodies, Monoclonal, Humanized
  • Interferon-alpha
  • Nitrosourea Compounds
  • Bleomycin
  • Epirubicin
  • Zidovudine
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
  • Carboplatin
  • Vindesine
  • Prednisone
  • mogamulizumab
  • Methotrexate

Supplementary concepts

  • CEV protocol
  • CHOP protocol
  • EPOCH protocol
  • LSG15 regimen
  • VAP-cyclo protocol
  • VEPA-B protocol
  • VEPA-M protocol